Results 1 to 10 of about 2,828,690 (175)
Clinical Case Reports, 2023 Key Clinical Message Neuromyelitis optica spectrum disorders can less commonly present with area postrema syndrome progressing to myelitis. Management involves intravenous glucocorticoids, plasma exchange, and preventive immunotherapy.
Preethi Jagannath +6 more
doaj +2 more sources
Neural Regeneration Research, 2019 Variants at the GTF2I repeat domain containing 1 (GTF2IRD1)–GTF2I locus are associated with primary Sjögren’s syndrome, systemic lupus erythematosus, and rheumatoid arthritis.
Jing-Lu Xie +9 more
doaj +2 more sources
Frontiers in Neurology, 2022 BackgroundNeuromyelitis optica spectrum disorders seriously hinder social participation. Only clarifying the status of social participation and the factors most strongly influencing it can promote better-targeted support for those with neuromyelitis ...
Mengmeng Jia +7 more
doaj +1 more source
Neuromyelitis optica spectrum disorders and pregnancy
Chinese Journal of Contemporary Neurology and Neurosurgery, 2022 Neuromyelitis optica spectrum diseases (NMOSDs) is an autoimmune disease of central nervous system, which occurs frequently in women of childbearing age. NMOSDs may affect pregnancy planning and fertility, and the effect on pregnancy outcome is not clear.
LIU Qiang, ZHANG Qing, QUAN Chao
doaj +1 more source
Annals of Indian Academy of Neurology, 2021 Introduction: Neuromyelitis optica spectrum disorder (NMOSD) is an astrocytopathy with a predilection for the optic nerve, spinal cord, and brainstem. In this ambispective study, we evaluate clinical characteristics, responses to therapy, and disability ...
Nishita Singh +9 more
doaj +1 more source
Taiwan Journal of Ophthalmology, 2020 Over the past decade, the discovery of disease-specific aquaporin-4 antibodies has led to a better understanding of the diverse spectrum of disorders that are associated with neuromyelitis optica.
Kok-Tian Oo +3 more
doaj +1 more source
Neuromyelitis Optica with NMO-IgG/ Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India [PDF]
Journal of Clinical and Diagnostic Research, 2014 Neuromyelitis optica (also known as Devic’s disease) is an idiopathic, severe, demyelinating disease of the central nervous system that preferentially affects the optic nerve and spinal cord.
Manish Mittal, Garima Mittal
doaj +1 more source
Journal of Medical Case Reports, 2019 Background Neuromyelitis optica spectrum disorders are severe autoimmune inflammatory diseases of the central nervous system associated with the presence of immunoglobulin G antibodies against the water channel protein aquaporin-4.
Susanne Bejerot +6 more
doaj +1 more source
Frontiers in Immunology, 2021 BackgroundDemyelination diseases are complex puzzles that are not always straightforward to diagnose. Multiple sclerosis and neuromyelitis optica are two that are frequently encountered.
Ke Shang +7 more
doaj +1 more source
Neuromyelitis optica spectrum disorder (NMOSD) – diagnosis, epidemiology, clinical course, treatment
Aktualności Neurologiczne, 2019 Devic’s disease (neuromyelitis optica, NMO) was first described under this name in 1894, and it was originally thought of as a variant of multiple sclerosis.
Agnieszka Damiza-Detmer +4 more
doaj +1 more source